Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?

Jarosław Woroń

doi:10.5114/dr.2025.152177

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2025
vol. 112

Send email

Copy url:

abstract:

Review article

Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?

Jarosław Woroń

^{1, 2, 3}

Clinical Department of Anaesthesiology and Intensive Care, and Clinical Pharmacology Consultation Office, University Hospital, Krakow, Poland
Department of Clinical Pharmacology, Chair of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
University Center for Monitoring and Research on Adverse Drug Effects, Krakow, Poland

Dermatol Rev/Przegl Dermatol 2025, 112, 27-37

DOI: https://doi.org/10.5114/dr.2025.152177

Online publish date: 2025/05/15

View full text Get citation

PlumX metrics:

In dermatological practice, physicians are increasingly encountering patients with multimorbidity who are undergoing polypharmacy. This requires an understanding of the potential interactions between patients’ existing medications and the prescribed dermatological pharmacotherapy. Data from registries of drug-induced complications indicate that adverse effects commonly associated with adverse events often involve medications used in polytherapy. This article compiles the most frequent interactions encountered in dermatological practice.

keywords:

dermatology, pharmacotherapy, drug interactions

Indeks osobowy

Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?

Jarosław Woroń 1, 2, 3

dermatology, pharmacotherapy, drug interactions

Jarosław Woroń

^{1, 2, 3}